Open AccessEfficacy and safety of concurrent chemoradiation with weekly cisplatin ± low-dose celecoxib in locally advanced undifferentiated nasopharyngeal carcinoma: A phase II-III clinical trial
Author(s) -
Μohammad Mohammadianpanah,
Sasan Razmjou-Ghalaei,
Amin Shafizad,
Yaghoub Ashouri-Taziani,
Bijan Khademi,
Niloofar Ahmadloo,
Mansour Ansari,
Shapour Omidvari,
Mansoor Ahmad,
Mohammad Amin Mosleh-Shirazi
Publication year - 2011
Publication title -
journal of cancer research and therapeutics/journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/0973-1482.92013
Subject(s) - celecoxib , medicine , nasopharyngeal carcinoma , cisplatin , placebo , fluorouracil , phases of clinical research , chemotherapy , clinical trial , gastroenterology , adverse effect , oncology , urology , radiation therapy , pathology , alternative medicine
This is the first study that aimed to determine the efficacy and safety of concurrent chemoradiation with weekly cisplatin ± celecoxib 100 mg twice daily in locally advanced undifferentiated nasopharyngeal carcinoma.